title: Soluble endoglin levels during normotensive and hypertensive pregnancies.
authors.forename: Alexandre
authors.initials: A
authors.lastname: Hertig
authors.forename: Guillaume
authors.initials: G
authors.lastname: Lefevre
authors.forename: Karine
authors.initials: K
authors.lastname: Toumi
authors.forename: Eric
authors.initials: E
authors.lastname: Rondeau
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Capeau
authors.forename: Serge
authors.initials: S
authors.lastname: Uzan
authors.forename: Nadia
authors.initials: N
authors.lastname: Berkane
mesh_terms: D000328:Adult; D015703:Antigens, CD / Q000097:blood*; D016022:Case-Control Studies; D000071063:Endoglin; D005260:Female; D017359:HELLP Syndrome / Q000097:blood*; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D011225:Pre-Eclampsia / Q000097:blood*; D011247:Pregnancy; D011956:Receptors, Cell Surface / Q000097:blood*
chemical_list: D015703:Antigens, CD; C064206:ENG protein, human; D000071063:Endoglin; D011956:Receptors, Cell Surface